SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-019570
Filing Date
2020-11-13
Accepted
2020-11-13 16:27:13
Documents
2
Period of Report
2020-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2399
2 lslampoa.htm EX-24 8643
  Complete submission text file 0001567619-20-019570.txt   12516
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39531 | Film No.: 201311871